BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
NASDAQ·Healthcare·Biotechnology
$8.89
-0.17%
Mkt Cap $1.80B
Next Earnings
In 7 daysWed, May 6, 2026
EPS Estimate
$0.06
3 analysts
Revenue Estimate
$151.12M
Last quarter: beat by +1500.00% on EPS, +168.66% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.80B
P/E
7.47
Fwd P/E
32.82
P/S
2.06
Rev TTM
—
EPS TTM
$1.20